2m 2m 2m 2m 2m 2m 2m
Alteri Thera Sp ADS (ATHE)
NASDAQ
$4.55+$0.13 (+3.06%)
Price as of Aug 03, 2026 4:10 PM EDT- $80.0MMarket Cap
- -11.88%1-Year Change
- BiotechnologyIndustry
Alteri Thera Sp ADS (ATHE)
$4.55+$0.13 (+3.06%)
ATHE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.42 | ||
Change | -$0.08 (-1.78%) | ||
Open | $4.34 | ||
High | $4.78 | ||
Low | $4.34 | ||
Previous Close | $4.50 | ||
Volume | 3,794 | ||
30-Day Average Volume | 14,164 | ||
1-Week Change | -2.75% | ||
1-Month Change | -17.78% | ||
1-Year Change | -11.88% | ||
3-Year Change | 52.24% | ||
5-Year Change | -65.78% | ||
Fundamentals | |||
Shares Outstanding | 18.1M | ||
Total Assets | $46.0M | ||
Market Cap | $80.0M | ||
Enterprise Value | $46.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/09/2023 | ||